EDGAR Filing Documents for 0001346302-20-000024

Form 8-K - Current report:

SEC Accession No. 0001346302-20-000024

Filing Date

2020-04-24

Accepted

2020-04-24 16:17:17

Documents

Period of Report

2020-04-21

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	a42420form8-k.htm	8-K	56058
2	EX-3.1	exhibit31amendmentno1t.htm	EX-3.1	4175
3	EX-10.1	exhibit101ussmallbusin.htm	EX-10.1	74030
	Complete submission text file	0001346302-20-000024.txt		135631

Mailing Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601

Business Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601 844-445-5704

XERIS PHARMACEUTICALS INC (Filer) CIK: 0001346302 (see all company filings)